Literature DB >> 18502402

Inflammatory receptors and pathways in human NT2-N neurons during hypoxia and reoxygenation. Impact of acidosis.

Elisabeth Frøyland1, Camilla Skjaeret, Marianne S Wright, Marit Lunde Dalen, Milada Cvancarova, Cecilie Kasi, Terje Rootwelt.   

Abstract

Cytokines are released in response to brain injury and inflammation. By binding to receptors, they can cause, exacerbate or inhibit cellular injury and repair. We studied RNA expression of cytokine receptors and members of inflammatory pathways in human NT2-N neurons during 3 h of hypoxia and glucose deprivation followed by 21 h of reoxygenation, and the impact of acidosis. Right after acidotic hypoxia, RNA of IL-10RA and CXCR4 were significantly increased relative to acidotic control, while Bcl-2 and Bcl-xL were significantly decreased. After 21 h of neutral reoxygenation after neutral hypoxia, there was a significant increase in RNA of CXCR1 (relative quantification (RQ)=4.1, p<0.05), CXCR2 (3.6, p<0.05), CCR2 (3.8, p<0.05), Hsp70 (2.4, p<0.05), HIF-1alpha (1.5, p<0.001), TRAF6 (1.3, p<0.05) and TNFR1 (1.6, p<0.05). After 21 h of acidotic reoxygenation after acidotic hypoxia, we found a significant increase in RNA of IL-1R1, IL-10RA, CXCR4 and Hsp70 compared to control, and a significant decrease in FAS and TRAF6. There was a significant increase in Bax expression and a significant decrease in Bcl-2 and Bcl-xL expression in three out of four pH groups after 21 h of reoxygenation. Acidotic, relative to neutral, hypoxia and reoxygenation also influenced the expression of various genes. We conclude that inflammatory receptors and pathways are activated during hypoxia and reoxygenation in NT2-N neurons, and that this activation is pH dependent. This supports the concept that inflammatory pathways play a role in cerebral hypoxic-ischemic damage, and that they may represent important pharmacological targets.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502402     DOI: 10.1016/j.brainres.2008.04.038

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Targeting protein phosphatases for the treatment of inflammation-related diseases: From signaling to therapy.

Authors:  Jie Pan; Lisha Zhou; Chenyang Zhang; Qiang Xu; Yang Sun
Journal:  Signal Transduct Target Ther       Date:  2022-06-04

2.  Neuroprotective effects of ischemic preconditioning on global brain ischemia through up-regulation of acid-sensing ion channel 2a.

Authors:  Yifeng Miao; Weiqiao Zhang; Yuchang Lin; Xiaojie Lu; Yongming Qiu
Journal:  Int J Mol Sci       Date:  2010-01-12       Impact factor: 5.923

3.  Ex vivo acidic preconditioning enhances bone marrow ckit+ cell therapeutic potential via increased CXCR4 expression.

Authors:  Chiara Cencioni; Roberta Melchionna; Stefania Straino; Marta Romani; Claudia Cappuzzello; Valentina Annese; Joseph C Wu; Giulio Pompilio; Angela Santoni; Carlo Gaetano; Monica Napolitano; Maurizio C Capogrossi
Journal:  Eur Heart J       Date:  2011-07-22       Impact factor: 29.983

Review 4.  Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases.

Authors:  Joo Hong Woo; Jee Hoon Lee; Hyunmi Kim; Soo Jung Park; Eun-Hye Joe; Ilo Jou
Journal:  Exp Neurobiol       Date:  2015-05-11       Impact factor: 3.261

Review 5.  Tissue Acidosis Associated with Ischemic Stroke to Guide Neuroprotective Drug Delivery.

Authors:  Orsolya M Tóth; Ákos Menyhárt; Rita Frank; Dóra Hantosi; Eszter Farkas; Ferenc Bari
Journal:  Biology (Basel)       Date:  2020-12-11

Review 6.  ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology.

Authors:  Antero Salminen; Anu Kauppinen; Tiina Suuronen; Kai Kaarniranta; Johanna Ojala
Journal:  J Neuroinflammation       Date:  2009-12-26       Impact factor: 8.322

7.  Preferential activation of HIF-2α adaptive signalling in neuronal-like cells in response to acute hypoxia.

Authors:  Miguel A S Martín-Aragón Baudel; Mick T Rae; Mark G Darlison; Amy V Poole; Jennifer A Fraser
Journal:  PLoS One       Date:  2017-10-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.